Clinical Trial Update: The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD) [NA]

View source ↗

Summary

Clinical trial update examining the effects of bevacizumab and ranibizumab on ocular pulse amplitude in neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• Lucentis (ranibizumab)

Snippet

Sponsor: Sheba Medical Center | Conditions: Neovascular Age Related Macular Degeneration | NA | Status: UNKNOWN